Results 151 to 160 of about 9,060,069 (257)

Coexisting benign and malignant tumours: a cardiac angiosarcoma case report. [PDF]

Eur Heart J Case Rep
Holtrop TET, El Mathari S, Etnel J, Priesterbach-Ackley LP, Kluin J.   +4 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Giant Primary Ovarian Leiomyoma Mimicking Ovarian Malignancy in an Elderly Postmenopausal Woman: A Rare Case Report. [PDF]

Clin Case Rep
Lugata J, Batchu N, Mrosso O, Kabuhaya J, Pinches E, Maringo G, Maro E, Mchome B, Mremi A.   +8 more
europepmc   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Comment on "Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?" [PDF]

J Cancer Res Clin Oncol
Bhise MR, Akotkar A, Bhandari S, Gite KV.   +3 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Multiple primary tumors: Report of a case

, 2010
Multipl primer neoplaziler, bir hastada her biri ayrı, her biri malignitenin belirgin bir örneği olan ve birinin diğerinin metastazı olma olasılığı ekarte edilmiş tümörlerin varlığı şeklinde tanımlanır.
Özdemir, Süleyman, Karadağ, Demet, Sancak, Tanzer, Çağlar, Oya, Yinanc, Mehmet Ali   +4 more
core  

Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. [PDF]

Liver Int
Gillmeister A, Husman J, Schmelz R, Brückner S, Hampe J, Aust D, Zeissig S.   +6 more
europepmc   +1 more source

Uncovering G Protein‐Coupled Receptors: Novel Targets and Biomarkers for Predicting Glioma Prognosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Low‐grade gliomas (LGG) exhibit significant heterogeneity and recurrence risk. G protein‐coupled receptors (GPCR) contribute to glioma malignant progression, but their prognostic value remains unclear. This work attempts to formulate a GPCR‐based outcome‐predicting model for LGG. Methods Based on TCGA LGG data, the enrichment scores
Jun Yang, Dongxu Zhang, Dongyuan Liu, Da Lin, Hao Wang   +4 more
wiley   +1 more source

Malignancies in patients with inborn errors of immunity: insights from 20-years of clinical experience in Qatar. [PDF]

Front Immunol
Khalil SM, Adeli M, Mohamed S, Thalappil S, Taha SA, Gamil A, Charif H, Ben-Omran T, Ehlayel MS, Al-Nesf MA.   +9 more
europepmc   +1 more source